Effective medicinal plants against enterohaemorrhagic Escherichia coli O157:H7

Journal of Ethnopharmacology

Volumn 94, Issue 1, 2004, Pages 49-54

  Voravuthikunchai, Supayang ^a   Lortheeranuwat, Amornrat ^b   Jeeju, Wanpen ^b   Sririrak, Trechada ^b   Phongpaichit, Souwalak ^b   Supawita, Thanomjit ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Antibacterial activity; Antimicrobial assay; E. coli O157:H7; EHEC; Enterohaemorrhagic Escherichia coli; Haemorrhagic uremic syndrome; HUS; Medicinal plants; O157:H7; Verocytoxin

Indexed keywords

ACACIA CATECHU EXTRACT; ADHATODA VASICA EXTRACT; ALSTONIA SCHOLARIS EXTRACT; ANDROGRAPHIS PANICULATA EXTRACT; ARDISIA COORATA EXTRACT; BLUMEA BALSAMIFERA EXTRACT; BOESENBERGIA ROTUNDA EXTRACT; BRUCEA JAVANICA EXTRACT; CAMELLIA CHINESIS EXTRACT; CASSIA ALATA EXTRACT; CENTELLA ASIATICA EXTRACT; CORIANDRUM SATIVUM EXTRACT; CURCUMA LONGA EXTRACT; CURCUMA ZEDOARIA EXTRACT; DERRIS SCANDENS EXTRACT; DRACAENA LOUREIRI EXTRACT; DRYOPTERIS SYRMATICA EXTRACT; EPIGALLOCATECHIN GALLATE; EUPHORBIA THYMIFOLIA EXTRACT; GALLOCATECHIN; GARCINIA MANGOSTANA EXTRACT; HOLARRHENA ANTIDYSENTERICA EXTRACT; PELTOPHORUM PTEROCARPUM EXTRACT; PLANT MEDICINAL PRODUCT; PSIDIUM GUAJAVA EXTRACT; PUNICA GRANATUM EXTRACT; QUERCUS INFECTORIA EXTRACT; UNCARIA GAMBIR EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; WALSURA ROBUSTA EXTRACT;

AGAR GEL DIFFUSION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATION; CATTLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI O157; FILTER; GASTROINTESTINAL INFECTION; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI O157; HUMANS; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; PLANTS, MEDICINAL; THAILAND;

EID: 3242731310     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2004.03.036     Document Type: Article

References (30)

1. Alkofahi A., Masaadeh H., Al-Khalil S. Antimicrobial evaluation of some plant extracts of traditional medicine of Jordan. Alexandria Journal of Pharmaceutical Science. 28:1996;139-144
2. Bower J.R. Food-borne diseases: Shiga toxin producing E. coli (STEC). Pediatric Journal of Infectious Disease. 18:1999;909-910
3. Cowan M.M. Plant products as antimicrobial agents. Clinical Microbiology Review. 12:1999;564-582
4. Crockett C.O., Guede-Guina F., Pugh D., Vangah-Manda M., Robinson T.J., Qlubadewo J.O., Ochillo R.F. Cassia alata an the preclinical search for therapeutic agents for the treatment of opportunistic infections in AIDS patients. Cell Molecular Biology. 38:1992;505-511
5. Djipa D.C., Delmee M., Quetin-Leclercq J. Antimicrobial activity of bark extracts of Syzygium jambos (L.) Alston (Myrtaceae). Journal of Ethnopharmacology. 71:2000;307-313
6. Griffin P.M., Tauxe R.V. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiology Review. 13:1991;60-98
7. Hussein S.A.M., Barakat H.H., Merfort I., Nawwar M.A.M. Tannins from the leaves of Punica granatum. Phytochemistry. 45:1997;819-823
8. Karch H., Strockbine N.A., O'Brien A.D. Growth of Escherichia coli O157:H7 in the presence of trimethoprim sulfamethoxazole facilitates detection of Shiga-like toxin-producing strains by colony blot assay. FEM Microbiology Letter. 35:1986;141-145
9. Karmali, M.A., 1992. The association of Verocytotoxin and the classification hemolytic-uremic syndrome, in: Kaplan, B.S., Trompeter, R.S., Moake J.L. (Eds.), Hemolytic Uremic Syndrome and Thrombocytopenic Purpura, Marcel Dekker, New York, pp. 199-212.
10. Lorian, V., 1996. Antibiotics in Laboratory Medicine, fourth ed. Williams & Wilkins, Baltimore, National Committee for Clinical Laboratory Standards, 1998, Performance Standard for Antimicrobial Susceptibility Testing, 8th Informational Supplement, M100-S8: NCCLS.
11. McCutcheon, A.R., Ellis, S.M., Hancock, R.E.W., Towers, G.H.N., 1992. Antibiotic screening of medicinal plants of the British Columbian native peoples. Journal of Ethnopharmacology 37, 213-223.
12. NIHJ and Ministry of Health and Welfare VT 1991.1-1995.11, 1996. Infectious Agents Surveillance Report, vol. 17, pp. 1-2.
13. Nimri L.F., Meqdam M.M., Alkofahi A. Antibacterial activity of Jordanian medicinal plants. Pharmaceutical Biology. 37:1999;196-201
14. Ostroff S.M., Kobayashi J.M., Lewis J.H. Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. Journal of American Medical Association. 262:1989;355-359
15. Pai C.H., Ahmed N., Lior H., Johnson W.M., Sims H.V., Woods D.E. Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a 2-year prospective study. Journal of Infectious Disease. 157:1988;1054-1057
16. Paton J.C., Paton A.W. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clinical Microbioogical Review. 11:1998;450-479
17. Prashanth D., Asha M.K., Amit A. Antibacterial activity of Punica granatum. Fitoterapia. 72:2001;171-173
18. Redwane, A., Lazrek, H.B., Amarouch, H., Jana, M., 1998a. Molluscicidal activity of methylgallate. Fitoterapia LXIX, 169-170.
19. Redwane A., Lazrek H.B., Bouallam S., Markouk M., Amarouch H., Jana M. Larvicidal activity of extracts from Quercus lusitania var. infectoria galls (Oliv.). Journal of Ethnopharmacology. 79:2002;261-263
20. Riley L.W. The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis. Annual Review of Microbiology. 41:1987;383-407
21. Scalbert A. Antimicrobial properties of tannins. Phytochemistry. 30:1991;3875-3883
22. Scotland, S.M., Smith, H.R., Rowe, B., 1985. Two distinct toxins active on Vero cells from Escherichia coli O157, Lancet ii, 885-886.
23. Scotland S.M., Rowe B., Smith H.R., Willshaw G.A., Gross R.J. Verocytotoxin-producing strains of Escherichia coli from children with HUS and their detection by specific DNA probes. Journal of Medical Microbiology. 25:1988;237-243
24. Sugita-Konishi Y., Hara-Kudo Y., Amano F., Okubo T., Aoi N., Iwaki M., Kumagai S. Epigallocatechin galate and gallocatechin galate in green tea catechins inhibit extracellular release of Vero toxin from enterohemorrhagic Escherichia coli O157: H7. Biochimica et Biophytica Acta. 1472:1999;42-50
25. van de Kar, N.C.A.J, Roelofs, H.G.R., Muytjens, H.L., Tolboon, J.J.M., Chart, H., Monnens, L.A.H., 1994. Verocytotoxin-producing Escherichia coli infection in patients with hemolytic uremic syndrome and their family members in the Netherlands, in: Karmali, M.A., Goglio, A.G. (Eds.), Recent Advances in Verocytotoxin-Producing Escherichia coli Infections, Elsevier Science, Amsterdam, pp. 45-48.
26. Voravuthikunchai S.P., Lortheeranuwat A., Ninprom T., Popaya W., Pongpaichit S., Supawita T. Antibacterial activity of Thai medicinal plants against enterohaemorrhagic Escherichia coli O157:H7. Clinical Microbiology and Infection. 8(Suppl.1):2002;116-117
27. Waterspiel J.N., Ashkenazi S., Morrow A.L., Cleary T.G. Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin. Infection. 20:1992;25-29
28. Wells T., Barrett J., Griffin P.M. A university outbreak of Escherichia coli O157:H7 infections associated with roast beef and an unusually benign clinical course. Journal of Infectious Disease. 172:1995;1122-1125
29. Yoh M., Frimpong E.K., Honda T. Effect of antimicrobial agents, especially fosfomycin on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157: H7. FEM Immunology and Medical Microbiology. 19:1997b;57-64
30. Yoh M., Frimpong E.K., Voravuthikunchai S., Honda T. Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157: H7. Canadian Journal of Microbiology. 45:1999;732-739